Our Impact
Translating Science into Opportunity
impact through Bioinnovation
For over three decades, the Center for Biotechnology has driven bioscience growth and translated academic innovations into patient care.
Stats from 2013-2023
Stories behind the numbers
Featured Story:
Envisagenics
CFB helps Drive Envisagenics’ RNA Therapeutics Success
Envisagenics leverages AI-driven RNA splicing analytics for therapeutic discovery, with CFB providing key support in its launch and growth.
Learn more
Featured Story:
Codagenix
From Inception to Investment
Codagenix, who recently secured Series B financing, was spun out of an SBU laboratory in 2009 with the held of the CFB.
Learn more
JelikaLite
Developing a transformational neuromodulation platform for unmet needs in developmental pediatric disorders
CMTx Biotech
Commercializing proprietary small-molecules for the treatment of rare, orphan diseases to improve critical patient outcomes
HapticHeart Solutions
Developing a system and a wearable device that converts physiological signals into actionable haptic feedback
IAMBIC
Revolutionizing footwear with AI-driven biomechanics
NeoMatrix Therapeutics
Novel, bioactive peptides that prevent injury progression and thereby rescue tissue and speed healing
ingenious targeting laboratory
Leveraging over 30 years of experience in animal model generation, specializing in creating precise genetic models for progressive research
PolyNova Cardiovascular, Inc.
Developing novel heart valve replacement technology
Expanding Our Impact
Explore more stories of the Center for Biotechnology’s impact on companies, technology, and future leaders.